CASI Pharmaceuticals (CASIF) Current Taxes (2021 - 2023)

CASI Pharmaceuticals has reported Current Taxes for 3 years, with the latest figure at $481000.0 in Q4 2023.

• For the quarter ending Q4 2023, Current Taxes fell 74.68% year-over-year to $481000.0; the trailing twelve-month figure through Dec 2023 stood at $481000.0 (down 74.68% YoY), and the FY2023 full-year result was $481000.0, down 74.68% from the prior year.
• Current Taxes for Q4 2023 stood at $481000.0, down from $1.9 million in the prior quarter.
• The five-year high for Current Taxes was $1.9 million in Q4 2022, with the low at $481000.0 in Q4 2023.
• Historically, Current Taxes has averaged $1.0 million across 3 years, with a median of $652000.0 in 2021.
• Annual changes were most pronounced in 2022 — Current Taxes jumped 191.41% — and 2023, when it slumped 74.68%.
• CASI Pharmaceuticals' Current Taxes stood at $652000.0 in 2021, then jumped by 191.41% to $1.9 million in 2022, then sank by 74.68% to $481000.0 in 2023.
• The last three Current Taxes figures came in at $481000.0 (Q4 2023), $1.9 million (Q4 2022), and $652000.0 (Q4 2021), per Business Quant data.